LISATA THERAPEUTICS, INC. — Director's Dealing 2019

Jan 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2019-01-14

Reporting Person: BROWN GREGORY B (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-14	Restricted Stock Units	A	12121	$4.95	Acquired	27583	Direct

Footnotes

F1: Represents 12,121 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 14, 2020.

F2: Includes 12,121 unvested restricted stock units.